SOUTH KOREA · OPENDART
HK inno.N Corporation
HK이노엔 · 195940 · KOSDAQ · Healthcare · Drug Manufacturers—Specialty & Generic
Score
Not ranked: no net buying on the exchange by an individual insider in the last 180 days.
Insiders' buying price vs the latest close
Insiders paid 49,171.26 KRW a share on average (4 purchase lines, 3 buyers, 2026-01-14 – 2026-04-16). The close on 2026-10-16 was 26.7% below that price.
The latest purchase (2026-04-16) was at 51,700.00 KRW; the close was 30.3% below that price.
Prices paid are weighted by shares and taken from the filings; dividends are not counted. Not scored.
Insider trades on the exchange
Purchases and sales on the exchange in the last 12 months. The filing gives the settlement date; the trade date is two trading days earlier.
| Trade date | Insider | Role | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-16 | Yoon Sang Hyun | Vice chairman | Bought on the exchange | 1,920 | ₩51,700 | ₩99.3M | DART ↗ |
| 2026-04-03 | Kwak Dal Won | CEO | Bought on the exchange | 2,000 | ₩48,572 | ₩97.1M | DART ↗ |
| 2026-03-27 | Song Geun Seog | Vice president | Bought on the exchange | 1,500 | ₩51,776 | ₩77.7M | DART ↗ |
| 2026-01-14 | Kwak Dal Won | CEO | Bought on the exchange | 3,000 | ₩46,650 | ₩139.9M | DART ↗ |
Other changes in holdings · 2
Option exercises, grants, new shares, inheritance, gifts, off-exchange trades and trades by companies and funds. Not counted in the score.